WallStreetZenWallStreetZen

NASDAQ: SPRY
Ars Pharmaceuticals Inc Earnings & Revenue

SPRY past revenue growth

How has SPRY's revenue growth performed historically?
Company
-98.51%
Industry
81.78%
Market
19.94%
SPRY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SPRY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SPRY earnings and revenue history

Current Revenue
$10.0k
Current Earnings
-$49.7M
Current Profit Margin
-496,960%

SPRY Return on Equity

Current Company
-21.1%
Current Industry
16.8%
Current Market
28.2%
SPRY's Return on Equity (-21.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SPRY announces earnings.

SPRY Return on Assets

Current Company
-20.5%
Current Industry
3.2%
SPRY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SPRY Return on Capital Employed

Current Company
-22.2%
Current Industry
-42.4%
SPRY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SPRY vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SPRY$10.00k-$49.63M-$49.70M-95.97%N/A
NUVB$0.00-$68.73M-$68.87MN/AN/A
IMNM$12.68M-$231.19M-$232.03M+436.51%N/A
PRTC$3.33M-$30.24M-$65.70M-30.64%N/A
DNTH$2.26M-$43.10M-$42.36M-20.15%N/A

SPRY earnings dates

Next earnings date
Aug 8, 2024

Ars Pharmaceuticals Earnings & Revenue FAQ

What were SPRY's earnings last quarter?

On Invalid Date, Ars Pharmaceuticals (NASDAQ: SPRY) reported Q1 2024 earnings per share (EPS) of -$0.11, up 31.25% year over year. Total Ars Pharmaceuticals earnings for the quarter were -$10.29 million. In the same quarter last year, Ars Pharmaceuticals's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Ars Pharmaceuticals stock.

What was SPRY's earnings growth in the past year?

As of Q2 2024, Ars Pharmaceuticals's earnings has grown year over year. Ars Pharmaceuticals's earnings in the past year totalled -$49.70 million.

What is SPRY's earnings date?

Ars Pharmaceuticals's earnings date is Invalid Date. Add SPRY to your watchlist to be reminded of SPRY's next earnings announcement.

What was SPRY's revenue last quarter?

On Invalid Date, Ars Pharmaceuticals (NASDAQ: SPRY) reported Q1 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Ars Pharmaceuticals's revenue was $20.00 thousand.

What was SPRY's revenue growth in the past year?

As of Q2 2024, Ars Pharmaceuticals's revenue has grown -98.51% year over year. This is 180.3 percentage points lower than the US Biotechnology industry revenue growth rate of 81.78%. Ars Pharmaceuticals's revenue in the past year totalled $10.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.